Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Trading banner 1
Trading banner 2
Trading banner 3
Trading banner 4
Trading banner 5
Trading banner 6
Trading banner 7
Trading banner 8
Trading banner 9
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Amylx Pharmaceuticals Inc (AMLX) – Amylx Pharmaceuticals Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Amylyx Pharmaceuticals (AMLX) trades at $15.20, down 5.35% on the day amid bearish technical signals. The company reported negative earnings in Q1 2026, missing expectations, and shows significant negative profitability metrics with ROE at -63.26% and ROA at -58.49%. However, analyst sentiment remains overwhelmingly positive with 91% buy ratings and a $25 consensus price target, driven by anticipation of Phase 3 data for lead candidate avexitide expected in Q3 2026.
The investment thesis centers on the upcoming Phase 3 LUCIDITY trial readout for avexitide in post-bariatric hypoglycemia, with potential 2027 commercialization. While current fundamentals reflect a pre-revenue biotech with substantial losses, the stock offers binary event-driven upside. Key risks include clinical trial failure, cash burn rate, and dependence on a single pipeline asset for future valuation.
Read full analysis

Key Stats

  • Market Cap
    $1.64B
  • Sector
    Health
  • 3M Drawdown
    -19.77%
  • Enterprise Value
    $1.36B
  • Dividend Yield
    -
  • Trading Activity
    100% Buy | 0% Sell
  • Typical Hold Time
    6 days
$14.73
52W Low: $4.35
14 May 2025
52W High: $18.36
17 Apr 2026

Amylx Pharmaceuticals Inc (AMLX) is currently valued at a market capitalization of $1.64B, with an enterprise value of $1.36B. Over the past 52 weeks, Amylx Pharmaceuticals Inc has traded between a low of $4.35 and a high of $18.36, highlighting its annual price range. Over the past three months, Amylx Pharmaceuticals Inc has recorded a drawdown of -19.77%, reflecting recent price volatility. On average, investors hold Amylx Pharmaceuticals Inc for approximately 6 days, indicating typical investor behavior on the platform.

About Amylx Pharmaceuticals Inc

Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.


Technical Indicators
|
|
|
Overall Summary
Bearish (15)Neutral (9)Bullish (3)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $1.64B
  • Sector
    Health
  • 3M Drawdown
    -19.77%
  • Enterprise Value
    $1.36B
  • Dividend Yield
    -
  • Trading Activity
    100% Buy | 0% Sell
  • Typical Hold Time
    6 days
$14.73
52W Low: $4.35
14 May 2025
52W High: $18.36
17 Apr 2026

Amylx Pharmaceuticals Inc (AMLX) is currently valued at a market capitalization of $1.64B, with an enterprise value of $1.36B. Over the past 52 weeks, Amylx Pharmaceuticals Inc has traded between a low of $4.35 and a high of $18.36, highlighting its annual price range. Over the past three months, Amylx Pharmaceuticals Inc has recorded a drawdown of -19.77%, reflecting recent price volatility. On average, investors hold Amylx Pharmaceuticals Inc for approximately 6 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!